CLDN10 and gastric cancer: From the Kaplan-Meier Plotter, the results showed that overexpression of CLDN10 corresponded with an unfavorable prognosis for gastric cancer patients (Figure 3A, OS HR = 1.62, 95% CI = 1.36–1.92, p = 3.7e-8; Figure 3C, PFS HR = 1.48, 95% CI = 1.21–1.81, p = 0.00011).